Literature DB >> 32636146

French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy.

M Fieux1, V Franco-Vidal2, P Devic3, F Bricaire4, A Charpiot5, V Darrouzet2, L Denoix1, P Gatignol6, N Guevara7, M Montava8, J A Roch9, F Tankéré6, S Tronche10, F Veillon11, S Vergez12, C Vincent13, G Lamas6, S Tringali14.   

Abstract

AQFThe authors present the guidelines of the French Society of ENT and Head and Neck Surgery (SFORL) regarding the management of Bell's palsy in adults. After a literature review by a multidisciplinary workgroup, guidelines were drawn up based on retrieved articles and group-members' experience, then read over by an independent group to edit the final version. Guidelines were graded A, B, C or "expert opinion" according to decreasing level of evidence. Thorough ENT and neurological clinical examination is recommended in all patients presenting with peripheral facial palsy to confirm diagnosis of Bell's palsy. MRI with gadolinium enhancement should explore the entire course of the facial nerve, if possible within the first month. ENMG should be performed to assess prognosis for recovery. In confirmed Bell's palsy, corticosteroid therapy should be implemented as early as possible (ideally within 72h) at a dose of 1mg/kg/day for 7-10 days. Antiviral therapy should be associated to steroids in patients with severe and early-onset disease and in Ramsay-Hunt syndrome. Isolated antiviral therapy is not recommended. To date, there is no evidence that surgical facial nerve decompression provides benefit.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bell's palsy; Drug therapy; ENMG; Imaging; Physical therapy

Year:  2020        PMID: 32636146     DOI: 10.1016/j.anorl.2020.06.004

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  4 in total

1.  Clinical practice guidelines in idiopathic facial paralysis: systematic review using the appraisal of guidelines for research and evaluation (AGREE II) instrument.

Authors:  Neil N Luu; Kevin T Chorath; Brandon R May; Nuvid Bhuiyan; Alvaro G Moreira; Karthik Rajasekaran
Journal:  J Neurol       Date:  2021-01-03       Impact factor: 4.849

2.  Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response.

Authors:  Maria Pia Cicalese; Francesca Ferrua; Federica Barzaghi; Federica Cerri; Matteo Moro; Alessandro Aiuti; Paolo Silvani
Journal:  BMJ Case Rep       Date:  2022-02-08

3.  Peripheral facial palsy following COVID-19 vaccination: a practical approach to use the clinical situation as a guide.

Authors:  Nicolas Weiss; Valérie Pourcher; Claire Foirest; Kévin Bihan; Frédéric Tankéré; Helga Junot; Sophie Demeret; Rabab Debs; Elisabeth Maillart; Christine Lebrun-Frenay; Augustin Vigouroux; Maxime Caudron; Etienne Canouï; Georges Lamas
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-06       Impact factor: 2.618

4.  Prognostic and Clinical Role of Contrast Enhancement on Magnetic Resonance Imaging in Patients with Bell's Palsy.

Authors:  Volkan Yücel; Serra Özbal Güneş; Kemal Keseroğlu; Ömer Bayır; Mehmet Furkan Çırakoğlu; Emel Çadallı Tatar; Güleser Saylam; Sevilay Karahan; Orhan Yılmaz; Mehmet Hakan Korkmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2022-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.